This invention provides estrogen receptor modulators of formula I, having the structure ##STR00001## wherein R.sub.1, R.sub.2, R.sub.2a, R.sub.3, R.sub.3a, and R.sub.4, and X as defined in the specification, or a pharmaceutically acceptable salt thereof.

 
Web www.patentalert.com

< Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy

< Anti-angiogenic proteins and fragments and methods of use thereof

> DHEA composition and method

> Apoptosis inhibitor

~ 00299